Calcium acetate 667 MG Oral Capsule — RxCUI 359296
RxNorm drug concept · Semantic clinical drug
RxCUI 359296
Semantic clinical drug · SCD
● Current RxNorm concept 19 FDA products
37 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI359296
Official nameCalcium acetate 667 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascalcium acetate 667 MG (calcium 169 MG) Oral Capsule; calcium acetate 667 MG (Ca 169 MG) Oral Capsule
FDA products mapped19
Package NDCs mapped37
Reported Medicaid activity (SDUD)73,238 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Calcium Acetate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It lowers the phosphorus in your blood if you have end stage renal disease. Failing kidneys can't clear phosphorus well, so it builds up. Calcium acetate helps by binding phosphate...
- Take it by mouth with each meal. It needs to be in your stomach with your food to bind the phosphate. Your prescriber will adjust how many you take based on your blood tests, so fo...
- The most common are high blood calcium, nausea and vomiting. Some people also report dizziness, swelling or weakness. Call your doctor if you have ongoing nausea, constipation, poo...
- Avoid them unless your doctor says otherwise. Calcium supplements and calcium-based antacids add more calcium and raise the risk of high blood calcium. Check with me before taking...
🕸️ Concept Web — How Calcium acetate 667 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Calcium acetate 667 MG Oral Capsule
RxCUI 359296 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Calcium acetate
214342IN
-
Calcium acetate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Phoslo
219236BN
-
Phoslo
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Calcium acetate Oral Capsule
375787SCDF -
Calcium acetate Oral Product
1164959SCDG -
Calcium acetate Pill
1164960SCDG -
Calcium acetate Oral Capsule [Phoslo]
645215SBDF -
Phoslo Oral Product
1180633SBDG -
Phoslo Pill
1180634SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Calcium acetate Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Calcium acetate 667 MG
329618SCDC -
Calcium acetate 667 MG Oral Capsule [Phoslo]
645216SBD -
Calcium acetate 667 MG [Phoslo]
569651SBDC
-
Calcium acetate 667 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Calcium acetate 667 MG
SCDC · 329618 -
Calcium acetate Oral Capsule
SCDF · 375787 -
Calcium acetate Oral Product
SCDG · 1164959 -
Calcium acetate Pill
SCDG · 1164960
Brand-Name Concepts
-
Calcium acetate 667 MG Oral Capsule [Phoslo]
SBD · 645216 -
Calcium acetate 667 MG [Phoslo]
SBDC · 569651 -
Calcium acetate Oral Capsule [Phoslo]
SBDF · 645215 -
Phoslo Oral Product
SBDG · 1180633 -
Phoslo Pill
SBDG · 1180634 -
Phoslo
BN · 219236
📦 FDA Products & Package NDCs
19 products · 37 package NDCs
37 package NDCs map to RxCUI 359296 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00054-0088-13 | 30 CAPSULE in 1 BOTTLE (0054-0088-13) | Calcium Acetate | Hikma Pharmaceuticals USA Inc. | 2008-02-28 |
| 00054-0088-26 | 200 CAPSULE in 1 BOTTLE (0054-0088-26) | Calcium Acetate | Hikma Pharmaceuticals USA Inc. | 2008-02-28 |
| 00615-8632-39 | 30 CAPSULE in 1 BLISTER PACK (0615-8632-39) | Calcium Acetate | NCS HealthCare of KY, LLC dba Vangard Labs | 2026-04-16 |
| 00904-7119-06 | 50 BLISTER PACK in 1 CARTON (0904-7119-06) / 1 CAPSULE in 1... | Calcium Acetate | Major Pharmaceuticals | 2008-02-26 |
| 00904-7119-61 | 100 BLISTER PACK in 1 CARTON (0904-7119-61) / 1 CAPSULE in... | Calcium Acetate | Major Pharmaceuticals | 2008-02-26 |
| 16571-0813-20 | 200 CAPSULE in 1 BOTTLE, PLASTIC (16571-813-20) | Calcium Acetate | Rising Pharma Holdings, Inc. | 2021-11-01 |
| 23155-0531-02 | 200 CAPSULE in 1 BOTTLE (23155-531-02) | calcium acetate | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2015-07-07 |
| 23155-0531-10 | 1000 CAPSULE in 1 BOTTLE (23155-531-10) | calcium acetate | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2015-07-07 |
| 23155-0531-18 | 13600 CAPSULE in 1 CONTAINER (23155-531-18) | calcium acetate | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2015-07-07 |
| 50268-0203-15 | 50 BLISTER PACK in 1 BOX (50268-203-15) / 1 CAPSULE in 1 BL... | Calcium Acetate | AvPAK | 2026-05-28 |
| 53746-0590-01 | 100 CAPSULE in 1 BOTTLE (53746-590-01) | Calcium Acetate | Amneal Pharmaceuticals of New York LLC | 2014-10-08 |
| 53746-0590-05 | 500 CAPSULE in 1 BOTTLE (53746-590-05) | Calcium Acetate | Amneal Pharmaceuticals of New York LLC | 2014-10-08 |
| 53746-0590-20 | 200 CAPSULE in 1 BOTTLE (53746-590-20) | Calcium Acetate | Amneal Pharmaceuticals of New York LLC | 2014-10-08 |
| 55154-4169-00 | 10 BLISTER PACK in 1 BAG (55154-4169-0) / 1 CAPSULE in 1 BL... | Calcium Acetate | Cardinal Health 107, LLC | 2008-02-26 |
| 62135-0191-22 | 200 CAPSULE in 1 BOTTLE (62135-191-22) | Calcium Acetate | Chartwell RX, LLC. | 2018-06-29 |
| 62135-0191-30 | 30 CAPSULE in 1 BOTTLE (62135-191-30) | Calcium Acetate | Chartwell RX, LLC. | 2018-06-29 |
| 62135-0191-73 | 750 CAPSULE in 1 BOTTLE (62135-191-73) | Calcium Acetate | Chartwell RX, LLC. | 2018-06-29 |
| 68084-0479-01 | 100 BLISTER PACK in 1 CARTON (68084-479-01) / 1 CAPSULE in... | Calcium Acetate | American Health Packaging | 2013-07-18 |
| 69097-0862-03 | 60 CAPSULE in 1 BOTTLE (69097-862-03) | Calcium Acetate | Cipla USA Inc., | 2016-07-26 |
| 69097-0862-83 | 200 CAPSULE in 1 BOTTLE (69097-862-83) | Calcium Acetate | Cipla USA Inc., | 2016-07-26 |
| 69367-0411-02 | 200 CAPSULE in 1 BOTTLE (69367-411-02) | Calcium Acetate | Westminster Pharmaceuticals, LLC | 2025-06-13 |
| 70518-4299-00 | 30 CAPSULE in 1 BLISTER PACK (70518-4299-0) | calcium acetate | REMEDYREPACK INC. | 2025-03-02 |
| 72789-0422-97 | 200 CAPSULE in 1 BOTTLE, PLASTIC (72789-422-97) | Calcium Acetate | PD-Rx Pharmaceuticals, Inc. | 2024-07-16 |
| 73190-0031-20 | 200 CAPSULE in 1 BOTTLE (73190-031-20) | calcium acetate | AvKARE | 2025-05-21 |
| 75834-0323-02 | 200 CAPSULE in 1 BOTTLE (75834-323-02) | Calcium Acetate | Nivagen Pharmaceuticals, Inc. | 2023-12-07 |
| 76282-0377-02 | 200 CAPSULE in 1 BOTTLE (76282-377-02) | Calcium Acetate | EXELAN PHARMACEUTICALS, INC. | 2014-04-14 |
| 76282-0377-60 | 60 CAPSULE in 1 BOTTLE (76282-377-60) | Calcium Acetate | EXELAN PHARMACEUTICALS, INC. | 2014-04-14 |
| 76483-0086-00 | 200 CAPSULE in 1 BOTTLE (76483-086-00) | Calcium Acetate | SQUARE PHARMACEUTICALS LIMITED | 2023-05-31 |
| 82804-0968-00 | 100 CAPSULE in 1 BOTTLE (82804-968-00) | Calcium Acetate | Proficient Rx LP | 2025-06-25 |
| 82804-0968-20 | 20 CAPSULE in 1 BOTTLE (82804-968-20) | Calcium Acetate | Proficient Rx LP | 2025-06-25 |
| 82804-0968-30 | 30 CAPSULE in 1 BOTTLE (82804-968-30) | Calcium Acetate | Proficient Rx LP | 2025-06-25 |
| 82804-0968-55 | 500 CAPSULE in 1 BOTTLE (82804-968-55) | Calcium Acetate | Proficient Rx LP | 2025-06-25 |
| 82804-0968-60 | 60 CAPSULE in 1 BOTTLE (82804-968-60) | Calcium Acetate | Proficient Rx LP | 2025-06-25 |
| 82804-0968-64 | 240 CAPSULE in 1 BOTTLE (82804-968-64) | Calcium Acetate | Proficient Rx LP | 2025-06-25 |
| 82804-0968-72 | 120 CAPSULE in 1 BOTTLE (82804-968-72) | Calcium Acetate | Proficient Rx LP | 2025-06-25 |
| 82804-0968-78 | 180 CAPSULE in 1 BOTTLE (82804-968-78) | Calcium Acetate | Proficient Rx LP | 2025-06-25 |
| 82804-0968-90 | 90 CAPSULE in 1 BOTTLE (82804-968-90) | Calcium Acetate | Proficient Rx LP | 2025-06-25 |
Observed labelers:
Proficient Rx LP (9) ·
Amneal Pharmaceuticals of New York LLC (3) ·
Chartwell RX, LLC. (3) ·
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (3) ·
Cipla USA Inc., (2) ·
EXELAN PHARMACEUTICALS, INC. (2)
· +13 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.1733
Range $0.1733–$0.1733
· middle 50% $0.1733–$0.1733
· 12 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.